Conducting Clinical Trials in the Time of a Pandemic
- PMID: 32520739
- PMCID: PMC7299100
- DOI: 10.1097/SLA.0000000000004114
Conducting Clinical Trials in the Time of a Pandemic
Conflict of interest statement
The authors report no conflicts of interest.
Figures
References
-
- United States Food and Drug Administration. FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. 2020. Available at: fda.gov/media/136238/download. Accessed March 18, 2020.
-
- Madhav N, Oppenheim B, Gallivan M, et al. Pandemics: risks, impacts, and mitigation. In: rd, Jamison DT, Gelband H, et al, eds. Disease Control Priorities: Improving Health and Reducing Poverty. Washington (DC); 2017.
-
- McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA 2020. - PubMed